The industry has and continues to be under significant pressure from policy-makers to allow the publication of section eight of the PBAC meeting agenda - pricing matters - but this is one of the few areas of the system over which the industry holds virtually all the power.
Latest Video
New Stories
-
PYC reports strong clinical momentum and cash position ahead of key readouts
October 27, 2025 - - Australian Biotech -
Government backs new national push to close bone health testing gap for women
October 27, 2025 - - Latest News -
Leadership change at PolyNovo as long-time Chair steps down
October 27, 2025 - - Australian Biotech -
Cann Group announces major debt restructure and capital raise to strengthen balance sheet
October 27, 2025 - - Australian Biotech -
FDA awards the first-ever national priority vouchers to nine sponsors
October 27, 2025 - - Latest News -
Cancer Australia looks to accelerate the delivery of national plan
October 27, 2025 - - Latest News -
Mark Butler announces the addition of another contraceptive option to the PBS
October 27, 2025 - - Latest News
